title: Mcl1 becomes ubiquitin-ous: new opportunities to antagonize a pro-survival protein.
authors.affiliation: Division of Oncology, The Children's Hospital of Philadelphia, Department of Pediatrics, The University of Pennsylvania School of Medicine, Colket Translational Research Building, Room 3020, 3501 Civic Center Boulevard, Philadelphia, PA 19104, USA. hogartym@email.chop.edu
authors.forename: Michael D
authors.initials: MD
authors.lastname: Hogarty
mesh_terms: D006801:Humans; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D025521:Tumor Suppressor Proteins; D025801:Ubiquitin / Q000378:metabolism; D043222:Ubiquitin Thiolesterase / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism
chemical_list: D064549:Myeloid Cell Leukemia Sequence 1 Protein; D019253:Proto-Oncogene Proteins c-bcl-2; D025521:Tumor Suppressor Proteins; C506234:USP9X protein, human; D025801:Ubiquitin; C502830:HUWE1 protein, human; D044767:Ubiquitin-Protein Ligases; D043222:Ubiquitin Thiolesterase